Arrowhead Property Plant And Equipment Net vs Non Currrent Assets Other Analysis

ARWR Stock

USD 25.24 0.05 0.20%

Arrowhead Pharmaceuticals financial indicator trend analysis is way more than just evaluating Arrowhead Pharmaceuticals prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Arrowhead Pharmaceuticals is a good investment. Please check the relationship between Arrowhead Pharmaceuticals Property Plant And Equipment Net and its Non Currrent Assets Other accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arrowhead Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

To learn how to invest in Arrowhead Stock, please use our How to Invest in Arrowhead Pharmaceuticals guide.

Property Plant And Equipment Net vs Non Currrent Assets Other

Property Plant And Equipment Net vs Non Currrent Assets Other Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Arrowhead Pharmaceuticals Property Plant And Equipment Net account and Non Currrent Assets Other. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Arrowhead Pharmaceuticals' Property Plant And Equipment Net and Non Currrent Assets Other is 0.97. Overlapping area represents the amount of variation of Property Plant And Equipment Net that can explain the historical movement of Non Currrent Assets Other in the same time period over historical financial statements of Arrowhead Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Arrowhead Pharmaceuticals' Property Plant And Equipment Net and Non Currrent Assets Other is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Property Plant And Equipment Net of Arrowhead Pharmaceuticals are associated (or correlated) with its Non Currrent Assets Other. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Currrent Assets Other has no effect on the direction of Property Plant And Equipment Net i.e., Arrowhead Pharmaceuticals' Property Plant And Equipment Net and Non Currrent Assets Other go up and down completely randomly.

Correlation Coefficient

0.97

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Non Currrent Assets Other

Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.

Most indicators from Arrowhead Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Arrowhead Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arrowhead Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

To learn how to invest in Arrowhead Stock, please use our How to Invest in Arrowhead Pharmaceuticals guide.At this time, Arrowhead Pharmaceuticals' Tax Provision is relatively stable compared to the past year. As of 06/06/2024, Enterprise Value is likely to grow to about 3.3 B, while Selling General Administrative is likely to drop slightly above 79.1 M.

	2021	2022	2023	2024 (projected)
Gross Profit	243.2M	228.2M	262.5M	275.6M
Total Revenue	243.2M	240.7M	276.8M	290.7M

Gross Profit Total Revenue

Arrowhead Pharmaceuticals fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock	Current Deferred Revenue	Non Current Liabilities Total
Total Assets		0.9	-0.68	0.26	0.78	0.87	0.04	-0.92	0.79	0.66	0.93	0.76	0.54	0.24	0.76	0.87	-0.72	0.67	0.95	0.92	0.85	0.53	0.74	0.26	0.36	0.88
Short Long Term Debt Total	0.9		-0.92	-0.12	0.5	0.99	0.38	-0.88	0.9	0.38	0.97	0.93	0.17	-0.1	0.63	0.72	-0.91	0.7	0.88	0.95	0.97	0.15	0.83	0.24	0.02	0.97
Other Current Liab	-0.68	-0.92		0.42	-0.28	-0.94	-0.52	0.7	-0.91	-0.16	-0.87	-0.97	0.18	0.36	-0.42	-0.5	0.87	-0.5	-0.71	-0.77	-0.94	0.2	-0.84	-0.02	0.28	-0.85
Total Current Liabilities	0.26	-0.12	0.42		0.42	-0.2	-0.72	-0.14	-0.24	0.63	-0.06	-0.35	0.82	0.78	0.26	0.33	0.26	0.16	0.13	0.13	-0.22	0.83	0.01	0.28	0.98	-0.05
Total Stockholder Equity	0.78	0.5	-0.28	0.42		0.49	-0.4	-0.63	0.54	0.8	0.63	0.43	0.64	0.37	0.7	0.78	-0.17	0.17	0.8	0.48	0.52	0.64	0.51	-0.14	0.39	0.41
Property Plant And Equipment Net	0.87	0.99	-0.94	-0.2	0.49		0.42	-0.86	0.94	0.33	0.98	0.97	0.07	-0.12	0.61	0.7	-0.89	0.62	0.88	0.91	0.99	0.06	0.82	0.13	-0.07	0.95
Net Debt	0.04	0.38	-0.52	-0.72	-0.4	0.42		-0.17	0.32	-0.71	0.31	0.46	-0.61	-0.38	-0.17	-0.16	-0.56	0.26	0.06	0.29	0.41	-0.62	0.04	0.12	-0.62	0.42
Retained Earnings	-0.92	-0.88	0.7	-0.14	-0.63	-0.86	-0.17		-0.78	-0.51	-0.89	-0.76	-0.42	-0.09	-0.83	-0.91	0.78	-0.7	-0.94	-0.9	-0.84	-0.41	-0.69	-0.3	-0.23	-0.88
Accounts Payable	0.79	0.9	-0.91	-0.24	0.54	0.94	0.32	-0.78		0.36	0.94	0.97	-0.05	-0.14	0.6	0.66	-0.73	0.39	0.86	0.76	0.97	-0.06	0.84	-0.16	-0.17	0.81
Cash	0.66	0.38	-0.16	0.63	0.8	0.33	-0.71	-0.51	0.36		0.43	0.24	0.75	0.33	0.65	0.71	-0.13	0.27	0.62	0.44	0.33	0.76	0.56	0.06	0.63	0.32
Non Current Assets Total	0.93	0.97	-0.87	-0.06	0.63	0.98	0.31	-0.89	0.94	0.43		0.94	0.2	0.04	0.66	0.76	-0.82	0.58	0.93	0.92	0.98	0.19	0.81	0.09	0.05	0.93
Non Currrent Assets Other	0.76	0.93	-0.97	-0.35	0.43	0.97	0.46	-0.76	0.97	0.24	0.94		-0.13	-0.21	0.52	0.59	-0.81	0.43	0.81	0.79	0.99	-0.14	0.83	-0.09	-0.25	0.85
Cash And Short Term Investments	0.54	0.17	0.18	0.82	0.64	0.07	-0.61	-0.42	-0.05	0.75	0.2	-0.13		0.53	0.51	0.59	-0.06	0.46	0.4	0.38	0.02	1.0	0.11	0.51	0.84	0.23
Net Receivables	0.24	-0.1	0.36	0.78	0.37	-0.12	-0.38	-0.09	-0.14	0.33	0.04	-0.21	0.53		0.12	0.14	0.25	-0.04	0.13	0.12	-0.1	0.55	-0.14	0.03	0.74	-0.02
Common Stock Total Equity	0.76	0.63	-0.42	0.26	0.7	0.61	-0.17	-0.83	0.6	0.65	0.66	0.52	0.51	0.12		0.93	-0.45	0.49	0.85	0.64	0.6	0.51	0.55	0.16	0.28	0.6
Common Stock Shares Outstanding	0.87	0.72	-0.5	0.33	0.78	0.7	-0.16	-0.91	0.66	0.71	0.76	0.59	0.59	0.14	0.93		-0.52	0.57	0.92	0.75	0.68	0.59	0.66	0.21	0.38	0.69
Inventory	-0.72	-0.91	0.87	0.26	-0.17	-0.89	-0.56	0.78	-0.73	-0.13	-0.82	-0.81	-0.06	0.25	-0.45	-0.52		-0.82	-0.66	-0.9	-0.84	-0.04	-0.64	-0.47	0.09	-0.95
Other Current Assets	0.67	0.7	-0.5	0.16	0.17	0.62	0.26	-0.7	0.39	0.27	0.58	0.43	0.46	-0.04	0.49	0.57	-0.82		0.53	0.84	0.52	0.44	0.41	0.84	0.32	0.81
Other Stockholder Equity	0.95	0.88	-0.71	0.13	0.8	0.88	0.06	-0.94	0.86	0.62	0.93	0.81	0.4	0.13	0.85	0.92	-0.66	0.53		0.84	0.88	0.4	0.76	0.07	0.2	0.82
Total Liab	0.92	0.95	-0.77	0.13	0.48	0.91	0.29	-0.9	0.76	0.44	0.92	0.79	0.38	0.12	0.64	0.75	-0.9	0.84	0.84		0.86	0.37	0.72	0.46	0.27	0.98
Property Plant And Equipment Gross	0.85	0.97	-0.94	-0.22	0.52	0.99	0.41	-0.84	0.97	0.33	0.98	0.99	0.02	-0.1	0.6	0.68	-0.84	0.52	0.88	0.86		0.01	0.83	0.01	-0.11	0.91
Total Current Assets	0.53	0.15	0.2	0.83	0.64	0.06	-0.62	-0.41	-0.06	0.76	0.19	-0.14	1.0	0.55	0.51	0.59	-0.04	0.44	0.4	0.37	0.01		0.11	0.5	0.85	0.22
Short Term Debt	0.74	0.83	-0.84	0.01	0.51	0.82	0.04	-0.69	0.84	0.56	0.81	0.83	0.11	-0.14	0.55	0.66	-0.64	0.41	0.76	0.72	0.83	0.11		-0.05	0.12	0.72
Common Stock	0.26	0.24	-0.02	0.28	-0.14	0.13	0.12	-0.3	-0.16	0.06	0.09	-0.09	0.51	0.03	0.16	0.21	-0.47	0.84	0.07	0.46	0.01	0.5	-0.05		0.42	0.42
Current Deferred Revenue	0.36	0.02	0.28	0.98	0.39	-0.07	-0.62	-0.23	-0.17	0.63	0.05	-0.25	0.84	0.74	0.28	0.38	0.09	0.32	0.2	0.27	-0.11	0.85	0.12	0.42		0.1
Non Current Liabilities Total	0.88	0.97	-0.85	-0.05	0.41	0.95	0.42	-0.88	0.81	0.32	0.93	0.85	0.23	-0.02	0.6	0.69	-0.95	0.81	0.82	0.98	0.91	0.22	0.72	0.42	0.1

Click cells to compare fundamentals

Arrowhead Pharmaceuticals Account Relationship Matchups

Arrowhead Pharmaceuticals fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	522.5M	710.1M	691.9M	765.6M	880.4M	924.4M
Other Current Liab	13.5M	23.8M	(5.6M)	(46.4M)	(53.4M)	(50.7M)
Total Current Liabilities	40.7M	146.5M	74.1M	866K	995.9K	946.1K
Total Stockholder Equity	461.8M	408.8M	106.0M	271.3M	312.0M	327.6M
Property Plant And Equipment Net	47.0M	66.0M	168.6M	335.6M	385.9M	405.2M
Net Debt	(122.4M)	(158.9M)	(26.4M)	4.3M	3.9M	4.0M
Retained Earnings	(503.8M)	(644.7M)	(820.8M)	(1.0B)	(923.4M)	(877.3M)
Accounts Payable	6.8M	9.5M	2.9M	35.9M	41.2M	43.3M
Cash	143.6M	184.4M	108.0M	110.9M	127.5M	133.9M
Non Current Assets Total	200.1M	325.6M	315.5M	654.7M	752.9M	790.5M
Non Currrent Assets Other	265.4K	272K	29.1M	361.9M	416.2M	437.0M
Cash And Short Term Investments	315.5M	367.8M	376.4M	110.9M	127.5M	83.7M
Net Receivables	327.4K	661.4K	845.7K	10.3M	1.4M	0.0
Common Stock Total Equity	187.9K	194.7K	197K	198K	227.7K	239.1K
Common Stock Shares Outstanding	100.7M	103.7M	105.4M	106.8M	122.8M	128.9M
Liabilities And Stockholders Equity	522.5M	710.1M	691.9M	765.6M	880.4M	924.4M
Inventory	3.3M	4.3M	4.4M	(21.6M)	(19.5M)	(18.5M)
Other Current Assets	1.8M	2.2M	20.2M	7.1M	8.1M	8.6M
Other Stockholder Equity	965.4M	1.1B	820.9M	1.3B	1.5B	1.6B
Total Liab	60.7M	301.3M	586.0M	478.4M	550.1M	577.7M
Property Plant And Equipment Gross	47.0M	88.9M	110.3M	377.5M	434.1M	455.8M
Total Current Assets	322.4M	384.6M	376.4M	110.9M	127.5M	85.9M
Accumulated Other Comprehensive Income	18.4K	(69K)	(136K)	(3.2M)	(2.9M)	(2.8M)
Short Term Debt	1.1M	2.3M	2.8M	10.6M	12.1M	12.8M
Common Stock	194.7K	197K	106.0M	200K	230K	218.5K
Current Deferred Revenue	19.3M	111.1M	74.1M	866K	995.9K	946.1K
Non Current Liabilities Total	20.0M	154.8M	511.9M	477.5M	549.2M	576.6M
Property Plant Equipment	30.9M	48.7M	110.3M	335.6M	385.9M	405.2M
Other Assets	68.9M	96.8M	218K	210K	241.5K	229.4K
Short Term Investments	171.9M	183.4M	268.4M	292.7M	336.6M	353.5M
Intangible Assets	15.4M	13.7M	12.0M	10.3M	11.8M	10.2M
Other Liab	8.7M	41.4M	190.3M	56.0M	64.3M	67.6M
Net Tangible Assets	446.4M	395.2M	398.5M	261.1M	300.2M	202.9M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Additional Tools for Arrowhead Stock Analysis

When running Arrowhead Pharmaceuticals' price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Arrowhead Property Plant And Equipment Net vs Non Currrent Assets Other Analysis

Property Plant And Equipment Net vs Non Currrent Assets Other

Property Plant And Equipment Net vs Non Currrent Assets Other Correlation Analysis

Correlation Coefficient

Property Plant And Equipment Net

Non Currrent Assets Other

Arrowhead Pharmaceuticals fundamental ratios Correlations

Arrowhead Pharmaceuticals Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Arrowhead Pharmaceuticals fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Additional Tools for Arrowhead Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Cash And Short Term Investments
Property Plant And Equipment Net	+ 0.99	Short Long Term Debt Total
Property Plant And Equipment Gross	+ 0.99	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 0.99	Non Currrent Assets Other
Current Deferred Revenue	+ 0.98	Total Current Liabilities
Non Current Assets Total	+ 0.98	Property Plant And Equipment Net

Non Currrent Assets Other	- 0.97	Other Current Liab
Non Current Liabilities Total	- 0.95	Inventory
Other Stockholder Equity	- 0.94	Retained Earnings
Property Plant And Equipment Gross	- 0.94	Other Current Liab
Property Plant And Equipment Net	- 0.94	Other Current Liab
Other Current Liab	- 0.92	Short Long Term Debt Total